As of 2026-03-21, the Relative Valuation of DarioHealth Corp (DRIO) is (182.57) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.99 USD, the upside of DarioHealth Corp based on Relative Valuation is -2385.0%.
The range of the Relative Valuation is (187.93) - (181.13) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 36.4x - 41.6x | 38.3x |
| Forward P/E multiples | 30.8x - 35.1x | 32.5x |
| Fair Price | (187.93) - (181.13) | (182.57) |
| Upside | -2452.1% - -2366.9% | -2385.0% |
| Date | P/E |
| 2026-03-20 | -1.55 |
| 2026-03-19 | -1.60 |
| 2026-03-18 | -1.73 |
| 2026-03-17 | -1.70 |
| 2026-03-16 | -1.63 |
| 2026-03-13 | -1.75 |
| 2026-03-12 | -1.76 |
| 2026-03-11 | -1.73 |
| 2026-03-10 | -1.77 |
| 2026-03-09 | -1.85 |
| 2026-03-06 | -1.88 |
| 2026-03-05 | -1.94 |
| 2026-03-04 | -1.82 |
| 2026-03-03 | -2.00 |
| 2026-03-02 | -2.08 |
| 2026-02-27 | -2.32 |
| 2026-02-26 | -2.18 |
| 2026-02-25 | -2.09 |
| 2026-02-23 | -2.18 |
| 2026-02-20 | -2.19 |
| 2026-02-19 | -2.22 |
| 2026-02-18 | -2.16 |
| 2026-02-17 | -2.24 |
| 2026-02-13 | -2.27 |
| 2026-02-12 | -2.18 |
| 2026-02-11 | -2.13 |
| 2026-02-10 | -2.00 |
| 2026-02-09 | -2.00 |
| 2026-02-06 | -1.93 |
| 2026-02-05 | -1.92 |
| 2026-02-04 | -1.96 |
| 2026-02-03 | -2.13 |
| 2026-02-02 | -2.12 |
| 2026-01-30 | -1.94 |
| 2026-01-29 | -2.00 |
| 2026-01-28 | -2.13 |
| 2026-01-27 | -2.15 |
| 2026-01-26 | -2.21 |
| 2026-01-23 | -2.26 |
| 2026-01-22 | -2.27 |
| 2026-01-21 | -2.34 |
| 2026-01-20 | -2.41 |
| 2026-01-16 | -2.41 |
| 2026-01-15 | -2.37 |
| 2026-01-14 | -2.30 |
| 2026-01-13 | -2.28 |
| 2026-01-12 | -2.26 |
| 2026-01-09 | -2.36 |
| 2026-01-08 | -2.50 |
| 2026-01-07 | -2.35 |